文献速递精神分裂症与精神病性障碍

精神分裂症的突触丢失:突触蛋白与mRNA的系统综述与荟萃分析

Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures.
PubMed 文献 · Mol Psychiatry · 2018-03-06

该系统综述与荟萃分析检索PubMed至2017年7月1日,纳入精神分裂症死后脑组织病例对照研究,量化突触蛋白或mRNA水平。发现海马、额叶和前扣带回的突触素显著降低,而额叶SNAP-25、PSD-95、VAMP和syntaxin无显著变化,提示突触丢失在脑区和蛋白间不均一。

要点

  • 精神分裂症患者海马、额叶和前扣带回突触素水平显著降低。
  • 额叶SNAP-25、PSD-95、VAMP和syntaxin水平无显著变化。
  • 突触丢失在脑区和蛋白类型间可能不均一。

核心结论

  • 精神分裂症患者海马和额叶皮质区突触素呈中至大幅降低,海马其他突触前和突触后蛋白也趋于降低,支持突触丢失参与精神分裂症病理生理。
  • 突触丢失在脑区和蛋白间可能存在差异,并非均匀一致。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed从建库至2017年7月1日。
  • 纳入精神分裂症病例对照死后脑组织研究,量化突触蛋白或mRNA水平。

主要发现

  • 海马突触素效应量为-0.65(p<0.01),额叶为-0.36(p=0.04),前扣带回为-0.54(p=0.02)。
  • 枕叶和颞叶皮质突触素无显著变化;额叶SNAP-25、PSD-95、VAMP和syntaxin无显著变化。
  • complexins、synapsins、rab3A、synaptotagmin及mRNA研究不足,无法荟萃分析;这些研究一般显示海马SNAP-25、PSD-95、synapsin和rab3A蛋白水平降低,其他脑区不一致。

关键数值与推荐

  • 海马突触素效应量-0.65(p<0.01),额叶-0.36(p=0.04),前扣带回-0.54(p=0.02)。
  • 枕叶和颞叶皮质突触素无显著变化;额叶SNAP-25、PSD-95、VAMP和syntaxin无显著变化。

临床怎么用

  • 突触素降低可作为精神分裂症突触病理的死后脑组织证据,支持突触丢失假说。
  • 脑区和蛋白差异提示未来研究需分别评估不同突触标志物。

局限性

  • complexins、synapsins、rab3A、synaptotagmin及mRNA研究不足,无法进行荟萃分析。
  • 其他脑区突触蛋白结果不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although synaptic loss is thought to be core to the pathophysiology of schizophrenia, the nature, consistency and magnitude of synaptic protein and mRNA changes has not been systematically appraised. Our objective was thus to systematically review and meta-analyse findings. The entire PubMed database was searched for studies from inception date to the 1st of July 2017. We selected case-control postmortem studies in schizophrenia quantifying synaptic protein or mRNA levels in brain tissue. The difference in protein and mRNA levels between cases and controls was extracted and meta-analysis conducted. Among the results, we found a significant reduction in synaptophysin in schizophrenia in the hippocampus (effect size: -0.65, p < 0.01), frontal (effect size: -0.36, p = 0.04), and cingulate cortices (effect size: -0.54, p = 0.02), but no significant changes for synaptophysin in occipital and temporal cortices, and no changes for SNAP-25, PSD-95, VAMP, and syntaxin in frontal cortex. There were insufficient studies for meta-analysis of complexins, synapsins, rab3A and synaptotagmin and mRNA measures. Findings are summarised for these, which generally show reductions in SNAP-25, PSD-95, synapsin and rab3A protein levels in the hippocampus but inconsistency in other regions. Our findings of moderate-large reductions in synaptophysin in hippocampus and frontal cortical regions, and a tendency for reductions in other pre- and postsynaptic proteins in the hippocampus are consistent with models that implicate synaptic loss in schizophrenia. However, they also identify potential differences between regions and proteins, suggesting synaptic loss is not uniform in nature or extent.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Osimo EF, Beck K, Reis Marques T, et al. Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures. Mol Psychiatry. 2018. PMID: 29511299. doi:10.1038/s41380-018-0041-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。